Outcome of resveratrol and resveratrol with donepezil combination on the β-amyloid plaques and neurofibrillary tangles in Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Outcome of resveratrol and resveratrol with donepezil combination on the β-amyloid plaques and neurofibrillary tangles in Alzheimer’s disease ; volume:14 ; number:8 ; day:1 ; month:8 ; year:2024 ; pages:1-17 ; date:8.2024
3 Biotech ; 14, Heft 8 (1.8.2024), 1-17, 8.2024

Creator: Rao, Y. Lakshmisha
Ganaraja, B.
Suresh, Pooja K.
Joy, Teresa
Ullal, Sheetal D.
Manjrekar, Poornima A.
Murlimanju, B. V.
Sharma, B. Gaurav
Massand, Amit
Agrawal, Amit

Contributor: SpringerLink (Online service)

DOI: 10.1007/s13205-024-04034-2

URN: urn:nbn:de:101:1-2410272135098.259560735146

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Rao, Y. Lakshmisha
Ganaraja, B.
Suresh, Pooja K.
Joy, Teresa
Ullal, Sheetal D.
Manjrekar, Poornima A.
Murlimanju, B. V.
Sharma, B. Gaurav
Massand, Amit
Agrawal, Amit
SpringerLink (Online service)

Other Objects (12)

Therapeutic potential of resveratrol in Alzheimer's disease

Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease

β-amyloid in Alzheimer’s disease initiation and phenotypic diversity

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond

High-frequency terahertz waves disrupt Alzheimer’s β-amyloid fibril formation

Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s disease

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Hochschulschrift

Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]

Hochschulschrift

Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]

Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Therapeutic potential of resveratrol in Alzheimer's disease

Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease

β-amyloid in Alzheimer’s disease initiation and phenotypic diversity

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond

High-frequency terahertz waves disrupt Alzheimer’s β-amyloid fibril formation

Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s disease

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Hochschulschrift

Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]

Hochschulschrift

Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]

Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Therapeutic potential of resveratrol in Alzheimer's disease

Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease

β-amyloid in Alzheimer’s disease initiation and phenotypic diversity

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond

High-frequency terahertz waves disrupt Alzheimer’s β-amyloid fibril formation

Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s disease

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Hochschulschrift

Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]

Hochschulschrift

Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]

Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Outcome of resveratrol and resveratrol with donepezil combination on the β-amyloid plaques and neurofibrillary tangles in Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Therapeutic potential of resveratrol in Alzheimer's disease

Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease

β-amyloid in Alzheimer’s disease initiation and phenotypic diversity

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond

High-frequency terahertz waves disrupt Alzheimer’s β-amyloid fibril formation

Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s disease

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]

Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]

Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Therapeutic potential of resveratrol in Alzheimer's disease

Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease

β-amyloid in Alzheimer’s disease initiation and phenotypic diversity

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond

High-frequency terahertz waves disrupt Alzheimer’s β-amyloid fibril formation

Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s disease

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]

Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]

Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Therapeutic potential of resveratrol in Alzheimer's disease

Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease

β-amyloid in Alzheimer’s disease initiation and phenotypic diversity

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond

High-frequency terahertz waves disrupt Alzheimer’s β-amyloid fibril formation

Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s disease

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]

Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]

Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Related objects

Reset password